September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Outcomes for Clinical Studies to Reduce Post-Operative Induction of Spherical Aberration for Myopic LASIK Surgeries
Author Affiliations & Notes
  • Guang-ming George Dai
    Ophthalmology, Abbott Medical Optics, Milpitas, California, United States
  • Dimitri Chernyak
    Ophthalmology, Abbott Medical Optics, Milpitas, California, United States
  • Sanjeev Kasthurirangan
    Ophthalmology, Abbott Medical Optics, Milpitas, California, United States
  • Janice Tarrant
    Ophthalmology, Abbott Medical Optics, Milpitas, California, United States
  • Footnotes
    Commercial Relationships   Guang-ming Dai, Abbott Medical Optics (E); Dimitri Chernyak, Abbott Medical Optics (E); Sanjeev Kasthurirangan, Abbott Medical Optics (E); Janice Tarrant, Abbott Medical Optics (E)
  • Footnotes
    Support  N/A
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4842. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Guang-ming George Dai, Dimitri Chernyak, Sanjeev Kasthurirangan, Janice Tarrant; Outcomes for Clinical Studies to Reduce Post-Operative Induction of Spherical Aberration for Myopic LASIK Surgeries. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4842.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the effectiveness of a new treatment algorithm to reduce post-operative induction of spherical aberration for myopic LASIK surgeries.

Methods : A new algorithm has been developed to reduce the induction of spherical aberration observed in LASIK surgeries. The process was postulated as a linear filtering operation to the cornea after the ablation and during the healing process. An optimization algorithm was employed to yield an optimized mathematical kernel that can be applied to develop modified ablation shapes. A clinical trial (STAR-114-SARA) was designed to test the effectiveness of the new algorithm. 26 myopic patients were recruited in Bogota, Columbia to participate in the study. The study was prospective, paired-eye randomized, single-center, contralateral study with the study eye treated with the new algorithm and the control eye treated with CustomVue®. The pre-operative MRSE ranges from -4 D to -12 D, with astigmatism up to 8 D. The patients’ ages range from 20 to 48. Post-operative refractions, acuities, OCT, subjective questionnaire, and high order aberration were collected in 1-day, 1-week, 1-month, and 3-month after surgery.

Results : The primary spherical aberration and secondary spherical aberration of both the study eyes and the control eyes were examined, together with other major HOA terms, such as coma and secondary astigmatism, over a 6 mm diameter and a 5 mm diameter, respectively. Over time, there is an increase of spherical aberration. However, the amount of spherical aberration at the same time point for the study eye is statistically significantly smaller than the control eye, both at 6 mm diameter and 5 mm diameter, indicating effectiveness of the new algorithm over previous treatments. At 6 mm diameter, the spherical aberration at 3-month post-op has a mean of 0.2 um for the study eyes and 0.26 um for the control eyes. The difference becomes more prominent at a smaller diameter. At 5 mm diameter, the spherical aberration at 3-month post-op has a mean of 0.02 um for the study eyes and 0.06 um for the control eyes. As for the visual acuities, there is no statistically significant difference between the two groups as expected, for both uncorrected and best-corrected acuities.

Conclusions : The study shows the effectiveness of the new algorithm to reduce the induction of spherical aberration for myopic LASIK surgeries.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×